leisure time -WSS

leisure time

author：explore 2025-10-02 23:31:08 - browse：4887

David Sabatini at home — David Sabatini posed at his home in Cambridge in 2022. Craig F. Walker/Boston Globe

Former MIT and Whitehead Institute star biologist David Sabatini, who lost his lofty positions after being accused of violating sexual harassment policies in 2021, is rejoining the Boston scientific community as head of a research group at a new laboratory under the umbrella of a Czech-based scientific institute.

Sabatini, who has denied harassing anyone and filed litigation over the claims, has been working since last October in a senior research position at the Institute of Organic Chemistry and Biochemistry, in the Czech Republic capital of Prague, investigating scientific questions in the areas of cell growth and metabolism, similar to his past research at Whitehead.

The Czech institute, known as IOCB Prague, is realizing a long-held ambition to expand into the Boston biotech hub, confirmed the institute’s director, Jan Konvalinka.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Former reverend arrested for allegedly killing 8

WSS

Why patients can’t get everything they want on drug pricing

Smaller biotechs seek to piggyback on weight loss drug boom

CDC Director Mandy Cohen on transparency, trust, and health

How AI can help patients find reliable information about doctors

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Search called off for baby washed away in Pennsylvania flash flood

explore

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

The haunting brain science of long Covid

Moonlake's readout produced a cash windfall. Risks remain

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

In Memoriam: Notable people who died in 2023

The problems with dementia villages

Hepatitis C has a cure — but many Americans still lack access to it

UHS says company favors patients whose insurance pays more

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

UnitedHealth, Optum discontinue NaviHealth name

focus

Results on Novartis prostate cancer therapy could expand its use

Former reverend arrested for allegedly killing 8

ADCs take center stage as promising cancer treatments

A new crop of companies is reshaping the health data economy

Dems pitch expanding Medicare power to negotiate drug prices

STAT Summit: How researchers deal with rejection

Wikipedia

knowledge

entertainment

knowledge